88137-001-01 - Initial

Manufacturer
OPTIMA COMMERCE LLC
Effective date
2026-11-09
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-11-13 02:02:03

Label at a glance#

ProductIrreshine Pain Relief Cream
Active ingredientMENTHOL
Label structure9 sections

Indications and uses

For the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises, sprains.

Dosage and administration

Adults and children 2 years of age and older: apply directly onto affected area without the need to rub, massage or bandage; repeat if necessary, but do not apply more than 3 to 4 times daily. Wash hands after use. Children under 2 years of age: do not use, consult a doctor.

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Menthol 4%

Purpose

OTC - PURPOSE SECTION

Topical Analgesic

Uses

INDICATIONS & USAGE SECTION

For the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises, sprains.

Warnings

WARNINGS SECTION

For external use only. Avoid contact with the eyes.

If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a physician.

When using this product

OTC - WHEN USING SECTION

Do not apply to wounds or damaged skin. Do not bandage tightly.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 2 years of age and older: apply directly onto affected area without the need to rub, massage or bandage; repeat if necessary, but do not apply more than 3 to 4 times daily. Wash hands after use.

Children under 2 years of age: do not use, consult a doctor.

Other information

OTHER SAFETY INFORMATION

Store at room temperature.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Allantoin, Ammonium Polyacryloyldimethyl Taurate, Arnica Montana Flower Extract, Butyrospermum Parkii (Shea) Butter, Caprylic/Capric Triglyceride, Caprylyl Glycol, Cetearyl Alcohol, Dimethicone, Dimethyl Sulfoxide, Ethylhexylglycerin, Glycerin, Glyceryl Stearate, Helianthus Annuus (Sunflower) Seed Oil, Lavandula Angustifolia (Lavender) Oil, Lecithin, Magnesium Chloride, Niacinamide, Panthenol, PEG-100 Stearate, Sodium Acrylates Copolymer, Sodium Citrate, Tocopheryl Acetate, Vanillyl Butyl Ether, Water.

Questions or comments?

OTC - QUESTIONS SECTION

Email: service@irreshiner.com

Irreshine Pain Relief Cream - 120 g

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

packagepackage
Irreshine

Pain Relief Cream

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130810228386783GTIN-13: 0810228386783
EAN-13: 0810228386783
GTIN-12: 810228386783
UPC-A: 810228386783
GTIN storage (14 digits): 00810228386783
Irreshine_Package_Label.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 25 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
88137-00188137-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 24 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Irreshine Pain Relief CreamMENTHOLOPTIMA COMMERCE LLC5fe3a227-7918-3dec-e063-6394a90a3d602026-11-09WarningsExact identifier
ndc (package): 88137-001-01
ndc (product): 88137-001
ndc11 (package): 88137000101
spl id: 5fe3a227-7919-3dec-e063-6394a90a3d60
spl set id: 5fe3a227-7918-3dec-e063-6394a90a3d60

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.